At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03759 PHARMARON
Not Yet Opened 10-22 16:08:35
26.060
-1.400
-5.10%
High27.880
Low25.220
Vol10.81M
Open27.500
D1 Closing27.460
Amplitude9.69%
Mkt Cap47.82B
Tradable Cap9.33B
Total Shares1.84B
T/O281.31M
T/O Rate3.02%
Tradable Shares358.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜PHARMARON Falls 5.46% in Regular Trading, CXO Selloff Resumes as Sector Pressure Returns
Medical and Pharmaceutical ETFs Gain Ground as CXO Stocks Rebound; Kanglong Chemical Surges 8%, Traditional Chinese Medicine Stocks Rally with Darentang Hitting Limit Up
Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The Company also operates through the others segment.